HT
ARCT icon

HAP Trading’s Arcturus Therapeutics ARCT Stock Holding History

HAP Trading’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.42M Buy
+77,142
New +$1.24M 0.1% 135

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

HAP Trading's ARCT Position: Q3 2025 in Review

HAP Trading opened a new position in Arcturus Therapeutics (ARCT) in Q3 2025: 77,142 shares worth $1.42M. The stake represents 0.1% of the portfolio and ranks #135 among its holdings.

136 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.

  • HAP Trading held 77,142 shares of Arcturus Therapeutics worth $1.42M as of Q3 2025.
  • Arcturus Therapeutics was a new HAP Trading position in Q3 2025.
  • Arcturus Therapeutics made up 0.1% of HAP Trading's portfolio in Q3 2025, its #135 holding.
  • 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.

Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.